The Notch pathway: a novel target for myocardial remodelling therapy?

Eur Heart J. 2014 Aug 21;35(32):2140-5. doi: 10.1093/eurheartj/ehu244. Epub 2014 Jun 26.

Abstract

Pathological ventricle remodelling, which follows a cardiac insult, causes heart failure. Despite the existence of multiple pharmaceutical approaches, heart failure is one of the leading causes of death worldwide and there is an urgent need to explore new therapeutic avenues. The Notch pathway is an evolutionary conserved fundamental pathway that regulates cell fate during development as well as throughout postnatal life in self-renewing tissues. In the myocardium, Notch signalling is involved in the modulation of cardiomyocytes survival, cardiac stem cells differentiation, and angiogenesis which are factors known to determine the extent of pathological cardiac remodelling. Modulation of the Notch pathway could become a tool to limit ventricle remodelling and the associated inexorable deterioration of cardiac performance.

Keywords: Apoptosis; Cardiomyocytes; Heart failure; Stem cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Calcium-Binding Proteins / metabolism
  • Cardiomegaly / physiopathology
  • Cardiomegaly / therapy
  • Cell Proliferation / physiology
  • Cell Survival
  • Heart Failure / therapy
  • Humans
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Membrane Proteins / metabolism
  • Myocardium / metabolism
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / metabolism
  • Receptor, ErbB-2 / metabolism
  • Receptors, Notch / physiology*
  • Serrate-Jagged Proteins
  • Signal Transduction / physiology*
  • Ventricular Remodeling / physiology*

Substances

  • Calcium-Binding Proteins
  • Intercellular Signaling Peptides and Proteins
  • Membrane Proteins
  • Receptors, Notch
  • Serrate-Jagged Proteins
  • ERBB2 protein, human
  • Receptor, ErbB-2